-
Signature
-
/s/ Robin Schulman, Attorney-in-Fact for Sytse Sijbrandij
-
Issuer symbol
-
GTLB
-
Transactions as of
-
14 May 2025
-
Net transactions value
-
-$5,758,611
-
Form type
-
4
-
Filing time
-
15 May 2025, 17:51:09 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Sijbrandij Sytse |
Executive Chair of the Board, Director, 10%+ Owner |
C/O GITLAB INC., NOT APPLICABLE |
/s/ Robin Schulman, Attorney-in-Fact for Sytse Sijbrandij |
15 May 2025 |
0001886022 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
GTLB |
Class A Common Stock |
Conversion of derivative security |
$0 |
+108,600 |
|
$0.000000 |
108,600 |
14 May 2025 |
By Trust |
F1, F2 |
| transaction |
GTLB |
Class A Common Stock |
Sale |
$4,825,087 |
-91,177 |
-84% |
$52.92 |
17,423 |
14 May 2025 |
By Trust |
F2, F3, F4 |
| transaction |
GTLB |
Class A Common Stock |
Sale |
$933,524 |
-17,423 |
-100% |
$53.58 |
0 |
14 May 2025 |
By Trust |
F2, F3, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
GTLB |
Class B Common Stock |
Conversion of derivative security |
|
-108,600 |
-0.66% |
|
16,376,872 |
14 May 2025 |
Class A Common Stock |
108,600 |
|
By Trust |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: